Christopher D. Breder, MD, PhD is a physician-scientist with extensive experience in both the pharmaceutical industry and the U.S. Food and Drug Administration (FDA). As a former FDA Medical Officer and Lead Medical Officer, he contributed to the review of numerous INDs and multiple NDA/BLA approvals across neurology, anesthesiology, and rare diseases. In industry, he has served in senior clinical development leadership roles at Sunovion, Supernus, and Bristol Myers Squibb, and now consults widely across biotech, investment, and legal sectors. Dr. Breder brings deep expertise in clinical trial design, regulatory strategy, safety assessment, and product development from early-stage programs through approval, and into life cycle management.